| Application no. and date | 12718549.4 (espacenet) (Federated) (European Patent Register), 20120425 | | Patent/reg. no. and date | DK/EP 2702155, 20170201 | | Publication date | 20140305 | | Priority no. and date | US 201161478767 P, 20110425, US 201161565779 P, 20111201 | | EP pub. no. and date |
EP 2702155 20140305 | | Effective date | | | Applicant/owner | Sanofi, 54, rue La Boétie
75008 Paris, FR | | Applicant ref. no. | Regulus REG-0025EP | | Inventor | BHAT, Balkrishen, 3545 Johns Hopkins Court
San Diego
California 92121, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61P 35/00 (2006.01) , A61P 43/00 (2006.01) , C12N 15/113 (2010.01) | | Title | MIKRO-RNA-FORBINDELSER OG FREMGANGSMÅDER TIL MODULERING AF MIR-21-AKTIVITET | | Int. application no. | US2012034880 | | Int. publication no. | WO2012148952 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
